RNA Urine Test Outperforms Standard Bladder Cancer Tests and Could Guide Treatment

Researchers at Stanford Medicine and VA Palo Alto have developed a simple urine test that diagnoses bladder cancer more accurately than current standard methods. The innovative RNA test not only detects cancer with greater precision but also helps physicians assess treatment response and predict which patients will benefit most from immunotherapy versus chemotherapy. This advancement could personalize cancer care and improve outcomes by enabling doctors to tailor treatment strategies to each patient's specific cancer profile, reducing unnecessary treatments and their associated side effects.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: October 2, 2026 at 10:00 AM



